1.44
Context Therapeutics Inc Borsa (CNTX) Ultime notizie
Is Context Therapeutics Inc. stock positioned well for digital economyMarket Movers & Fast Entry Momentum Trade Alerts - newser.com
Is Context Therapeutics Inc. stock a defensive play in 2025Market Activity Summary & Weekly High Return Stock Forecasts - newser.com
Context Therapeutics Inc. recovery potential after sell offEarnings Recap Report & Accurate Technical Buy Alerts - newser.com
What drives Context Therapeutics Inc stock priceGrowth vs. Value Investing & Free High Yield Growth Strategies - earlytimes.in
D. Boral Capital Maintains Context Therapeutics (CNTX) Buy Recommendation - Nasdaq
Applying chart zones and confluence areas to Context Therapeutics Inc.2025 Price Momentum & AI Enhanced Trading Alerts - newser.com
Is Context Therapeutics Inc a good long term investmentMonthly Performance Summary & Access Free Tools and Start Investing - earlytimes.in
Is Context Therapeutics Inc. stock in correction or buying zone2025 Big Picture & Weekly High Return Opportunities - newser.com
Does Context Therapeutics Inc. stock trade at a discount to peersEarnings Recap Summary & Real-Time Volume Analysis Alerts - newser.com
Can a trend reversal in Context Therapeutics Inc. lead to recoveryJuly 2025 Sentiment & Entry Point Confirmation Alerts - newser.com
Momentum divergence signals in Context Therapeutics Inc. chartGap Down & Stepwise Trade Signal Implementation - newser.com
How to use Fibonacci retracement on Context Therapeutics Inc.2025 Technical Overview & Expert Verified Stock Movement Alerts - newser.com
Context Therapeutics to Present New Data on Two Bispecific T Cell Engagers at SITC 2025 - MyChesCo
Context Therapeutics to Showcase CT-95 Data at AACR 2025 - MSN
Is Context Therapeutics Inc. stock ready for a breakoutNew Guidance & Low Risk Entry Point Tips - newser.com
Will Context Therapeutics Inc. continue its uptrendLayoff News & AI Based Buy and Sell Signals - newser.com
Historical volatility pattern of Context Therapeutics Inc. visualizedQuarterly Earnings Summary & Community Supported Trade Ideas - newser.com
Real time social sentiment graph for Context Therapeutics Inc.Portfolio Update Summary & Free Weekly Watchlist of Top Performers - newser.com
Live market analysis of Context Therapeutics Inc.July 2025 Market Mood & Stepwise Swing Trade Plans - newser.com
Context Therapeutics Inc. stock momentum explained2025 Dividend Review & Risk Controlled Daily Trade Plans - newser.com
Weiss Ratings Reiterates Sell (D-) Rating for Context Therapeutics (NASDAQ:CNTX) - MarketBeat
How Context Therapeutics Inc. stock trades before earningsQuarterly Profit Summary & Consistent Growth Stock Picks - newser.com
Is a relief rally coming for Context Therapeutics Inc. holdersIndex Update & AI Driven Stock Reports - newser.com
Is Context Therapeutics Inc. showing signs of accumulationEarnings Summary Report & Stepwise Trade Signal Implementation - newser.com
Institutions profited after Context Therapeutics Inc.'s (NASDAQ:CNTX) market cap rose US$14m last week but private equity firms profited the most - Yahoo Finance
Context Therapeutics Inc. (NASDAQ:CNTX) Receives $5.20 Consensus PT from Analysts - Defense World
Context Therapeutics Grants Stock Options to New Hire - MSN
Will Context Therapeutics Inc. see short term momentumJuly 2025 Short Interest & Fast Moving Stock Watchlists - newser.com
Context Therapeutics Announces Poster Presentations at the - GlobeNewswire
Context Therapeutics Inc. to Present Trial Progress and Preclinical Data at SITC 2025 Annual Meeting - Quiver Quantitative
Context Therapeutics Announces Poster Presentations at the Society for Immunotherapy of ... - Caledonian Record
Context Therapeutics Announces Poster Presentations at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting - Stock Titan
Is it too late to sell Context Therapeutics Inc.2025 Winners & Losers & High Win Rate Trade Tips - newser.com
Context Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635(4) - MarketScreener
Developing predictive dashboards with Context Therapeutics Inc. dataJuly 2025 Update & AI Forecasted Entry/Exit Points - newser.com
Aclaris to Host 2025 R&D Day in New York to Spotlight Immuno-Inflammatory Pipeline - MyChesCo
Context Therapeutics Inc. (NASDAQ:CNTX) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Context Therapeutics announces inducement grant under Nasdaq listing rule - MarketScreener
GlobeNewswire by Notified - The Manila Times
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):